BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, February 21, 2026
Home
»
Topics
»
Disease categories and therapies
» Cancer
Cancer
RSS
SymBio completes enrollment in phase II study in indolent non-Hodgkin's lymphoma
June 2, 2008
Triphendiol safe in phase Ia pharmacokinetic study
June 2, 2008
Novartis pays USD 25 million milestone payment to Antisoma in relation to ASA-404
June 2, 2008
Genmab initiates phase I/II zalutumumab combination study in colorectal cancer
May 30, 2008
Cell-based osteoprotegerin therapy prevents bone metastasis in prostate cancer model
May 30, 2008
Alfacell presents phase IIIb results for Onconase trial in malignant mesothelioma
May 30, 2008
Advexin improves survival in recurrent, refractory head and neck cancer
May 30, 2008
Sonus and OncoGenex Technologies merge
May 29, 2008
BiPar Sciences commences phase II BSI-201 study in uterine carcinosarcoma
May 29, 2008
Sapacitabine receives EMEA orphan designation for AML and MDS
May 28, 2008
Previous
1
2
…
2813
2814
2815
2816
2817
2818
2819
2820
2821
…
4069
4070
Next